Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 352
Filter
Add more filters

Country/Region as subject
Publication year range
1.
Oral Dis ; 22(2): 132-9, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26582753

ABSTRACT

OBJECTIVE: Disruption of the third zinc finger domain of specificity protein 6 (SP6) presents an enamel-specific defect in a rat model of amelogenesis imperfecta (AMI rats). To understand the molecular basis of amelogenesis imperfecta caused by the Sp6 mutation, we established and characterized AMI-derived rat dental epithelial (ARE) cells. MATERIALS AND METHODS: ARE cell clones were isolated from the mandibular incisors of AMI rats, and amelogenesis-related gene expression was analyzed by reverse transcription polymerase chain reaction (RT-PCR). Localization of wild-type SP6 (SP6WT) and mutant-type SP6 (SP6AMI) was analyzed by immunocytochemistry. SP6 transcriptional activity was monitored by rho-associated protein kinase 1 (Rock1) promoter activity with its specific binding to the promoter region in dental (G5 and ARE) and non-dental (COS-7) epithelial cells. RESULTS: Isolated ARE cells were varied in morphology and gene expression. Both SP6WT and SP6AMI were mainly detected in nuclei. The promoter analysis revealed that SP6WT and SP6AMI enhanced Rock1 promoter activity in G5 cells but that enhancement by SP6AMI was weaker, whereas no enhancement was observed in the ARE and COS-7 cells, even though SP6WT and SP6AMI bound to the promoter in all instances. CONCLUSION: ARE cell clones can provide a useful in vitro model to study the mechanism of SP6-mediated amelogenesis imperfecta.


Subject(s)
Amelogenesis Imperfecta/pathology , Epithelial Cells/pathology , Kruppel-Like Transcription Factors/genetics , Kruppel-Like Transcription Factors/metabolism , Amelogenesis Imperfecta/genetics , Amelogenesis Imperfecta/metabolism , Animals , Cells, Cultured , Gene Expression , Incisor/pathology , Promoter Regions, Genetic , Rats , rho-Associated Kinases/genetics
2.
Reprod Domest Anim ; 50(5): 872-80, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26138589

ABSTRACT

The CRISPR/Cas9 system has enabled the editing of mammalian genomes; however, its applicability and efficiency in the pig genome has not been studied in depth. The α-gal epitope synthesized by α-1,3-galactosyltransferase gene (GGTA1) is known as a xenoantigen obtained upon pig-to-human xenotransplantation. We here employed the CRISPR/Cas9 system-mediated knock-in of endogenous GGTA1 via targeted homologous recombination (HR). Linearized donors with ~800-bp homology flanking the CRISPR/Cas9 target site [exon 4 (containing ATG) of GGTA1] served as a template for gene targeting by HR. Using a targeted toxin strategy to select clones lacking α-gal epitope expression, we successfully obtained several knock-in clones within 3 weeks of initial transfection. These results suggest that the use of CRISPR/Cas9-mediated HR to knock-in a mutated fragment at defined loci represents an efficient strategy to achieve the rapid modulation of genes of interest in swine cells and is a promising tool for the creation of KO piglets.


Subject(s)
CRISPR-Cas Systems/genetics , Fibroblasts/enzymology , Galactosyltransferases/deficiency , Gene Knock-In Techniques/veterinary , Sus scrofa/embryology , Animals , Clustered Regularly Interspaced Short Palindromic Repeats/genetics , Epitopes/genetics , Galactosyltransferases/genetics , Homologous Recombination/genetics , Mutation/genetics , Transfection/veterinary
3.
Pediatr Surg Int ; 30(8): 815-22, 2014 Aug.
Article in English | MEDLINE | ID: mdl-25052255

ABSTRACT

PURPOSE: Intestinal neuronal dysplasia Type B (IND-B) has been proposed to be an allied disorder of Hirschsprung's disease (ADHD). The original histological criteria included hyperganglionosis, giant ganglia, ectopic ganglion cells and an increased AChE activity in the lamina propria. The criteria for IND-B have been gradually revised. The present diagnostic criteria are [1] more than 20 % of the submucosal ganglia contain nine or more ganglion cells and [2] the patient is older than 1 year. To clarify the current status of IND-B in Japan, a nationwide retrospective cohort study was performed. METHODS: Questionnaires were sent to 161 major institutes of pediatric surgery and gastroenterology in Japan. RESULTS: A total of 355 cases of ADHD were collected, including 18 cases of IND-B (5 %). Based on original criteria, 13 out of 18 cases were diagnosed as IND-B. However, only four cases met the current criteria. Three of the four patients (75 %) required pull-through operation. All of the patients exhibited giant ganglia and ganglioneuromatosis-like hyperplasia of the myenteric plexus. CONCLUSIONS: IND-B cases matching the current criteria are thought to be quite rare and they are associated with marked hyperplasia of the myenteric plexus. "True" IND-B is a rare and intractable disease.


Subject(s)
Enteric Nervous System/pathology , Hirschsprung Disease/pathology , Intestinal Mucosa/innervation , Submucous Plexus/pathology , Adolescent , Child , Child, Preschool , Female , Hirschsprung Disease/epidemiology , Humans , Incidence , Intestinal Mucosa/pathology , Japan/epidemiology , Male , Retrospective Studies , Surveys and Questionnaires
4.
Br J Cancer ; 109(11): 2803-9, 2013 Nov 26.
Article in English | MEDLINE | ID: mdl-24169346

ABSTRACT

BACKGROUND: A previous clinical study in non-small cell lung cancer (NSCLC) patients in Western countries suggested the potential for combination of a first-in-class non-ATP-competitive c-Met inhibitor tivantinib with an epidermal growth factor receptor-tyrosine kinase inhibitor erlotinib. Polymorphisms of CYP2C19, the key metabolic enzyme for tivantinib, should be addressed to translate the previous Western study to Asian population, because higher incidence of poor metabolisers (PMs) is reported in Asian population. METHODS: Japanese patients with advanced/metastatic NSCLC received tivantinib in combination with erlotinib to evaluate safety and pharmacokinetics. Doses of tivantinib were escalated separately for extensive metabolisers (EMs) and PMs. RESULTS: Tivantinib, when combined with erlotinib, was well tolerated up to 360 mg BID for EMs and 240 mg BID for PMs, respectively. Among 25 patients (16 EMs and 9 PMs), the adverse events (AEs) related to tivantinib and/or erlotinib (>20%, any grade) were rash, diarrhoea, dry skin and nausea. Grade ≥3 AEs were leukopenia, anaemia and neutropenia. No dose-limiting toxicity was observed. Pharmacokinetics profile of tivantinib was not clearly different between the combination and monotherapy. Three partial response and three long-term stable disease (≥24 weeks) were reported. CONCLUSION: Two doses of tivantinib in combination with erlotinib were recommended based on CYP2C19 genotype: 360 mg BID for EMs and 240 mg BID for PMs.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Aryl Hydrocarbon Hydroxylases/genetics , Carcinoma, Non-Small-Cell Lung/drug therapy , Lung Neoplasms/drug therapy , Protein Kinase Inhibitors/administration & dosage , Pyrrolidinones/administration & dosage , Quinazolines/administration & dosage , Quinolines/administration & dosage , Antineoplastic Combined Chemotherapy Protocols/pharmacokinetics , Asian People , Carcinoma, Non-Small-Cell Lung/ethnology , Carcinoma, Non-Small-Cell Lung/genetics , Carcinoma, Non-Small-Cell Lung/pathology , Cytochrome P-450 CYP2C19 , Disease Progression , Drug Dosage Calculations , Erlotinib Hydrochloride , Female , Genotype , Humans , Lung Neoplasms/ethnology , Lung Neoplasms/genetics , Lung Neoplasms/pathology , Male , Middle Aged , Neoplasm Metastasis , Protein Kinase Inhibitors/adverse effects , Protein Kinase Inhibitors/pharmacokinetics , Proto-Oncogene Proteins c-met/antagonists & inhibitors , Pyrrolidinones/adverse effects , Pyrrolidinones/pharmacokinetics , Quinazolines/adverse effects , Quinazolines/pharmacokinetics , Quinolines/adverse effects , Quinolines/pharmacokinetics
5.
Phys Rev Lett ; 111(5): 056404, 2013 Aug 02.
Article in English | MEDLINE | ID: mdl-23952425

ABSTRACT

The fundamental electronic structure of the widely used battery material Li(x)CoO(2) still remains a mystery. Soft x-ray absorption spectroscopy of Li(x)CoO(2) reveals that holes with strong O 2p character play an essential role in the electronic conductivity of the Co(3+)/Co(4+) mixed valence CoO(2) layer. The oxygen holes are bound to the Co(4+) sites and the Li-ion vacancy, suggesting that the Li-ion flow can be stabilized by oxygen hole back flow. Such an oxygen hole state of Li(x)CoO(2) is unique among the various oxide-based battery materials and is one of the key ingredients to improving their electronic and Li-ion conductivities.

6.
Phys Rev Lett ; 111(12): 126104, 2013 Sep 20.
Article in English | MEDLINE | ID: mdl-24093280

ABSTRACT

Li(x)CoO(2) exhibits intriguing electronic properties due to a strong electron correlation and complex interplay between Co and Li ions. However, fundamental understanding of the nanoscale distribution of Li ions and its effect on the electronic properties remains unclear. We use scanning tunneling microscopy and density functional theory to elucidate the degree of Li(x)CoO(2) surface electronic state modification that can be achieved by Li ordering. The surface Li ions are highly mobile and preferentially form a (1 × 1) hexagonal lattice, whereas the surface CoO(2) layer shows metallic and insulating phases, indicating the coexistence of ordered and disordered Li ions in the subsurface layer. These results provide evidence of novel electronic properties produced by spatially inhomogeneous Li-ordering patterns.

7.
Reprod Domest Anim ; 47(3): 392-402, 2012 Jun.
Article in English | MEDLINE | ID: mdl-21906190

ABSTRACT

The present study was carried out to compare the gene expression profiles in oocytes derived from adult and prepubertal Japanese Black cattle during in vitro maturation (IVM) using microarray gene chips (Bovine genome array containing 24,072 probe sets representing over 23,000 transcripts). Microarray experiments were conducted using total RNA isolated from immature [germinal vesicle (GV)] and in vitro matured [metaphase II, (MII)] oocytes derived from adult and prepubertal animals. A total of 333 (1.4%) and 549 (2.3%) genes were differentially expressed between prepubertal vs adult bovine GV and MII stages oocytes, respectively. Of these, 176 and 312 genes were up-regulated, while 157 and 237 were down-regulated in prepubertal when compared with adult GV and MII oocytes, respectively. It was also observed that 695 (2.9%) and 553 (2.3%) genes were differentially expressed between GV vs MII stage oocytes in the adult and prepubertal groups, respectively. Gene ontological classification of the differentially expressed genes revealed that up-regulated genes in adult oocytes were involved in signal transduction, transcriptional control and transport. Quantitative reverse transcription-PCR validated the expression profile of some selected transcripts and confirmed differences in the expression levels of transcripts between adult vs prepubertal groups in both GV and MII stages oocytes as identified by microarray data analysis. This study indicated for the first time that significant number of genes were differentially expressed (>2-fold, p < 0.01) between oocytes derived from adult and those from prepubertal Japanese Black cattle, and this difference increased during IVM.


Subject(s)
Cattle/physiology , Gene Expression Profiling/veterinary , In Vitro Oocyte Maturation Techniques/veterinary , Oocytes/physiology , Sexual Maturation/physiology , Animals , Female , Gene Expression Regulation, Developmental/physiology , RNA, Messenger/genetics , RNA, Messenger/metabolism
8.
Reprod Domest Anim ; 47(5): 759-65, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22136322

ABSTRACT

Porcine embryonic fibroblasts (PEFs) are widely used as donor cells for somatic cell nuclear transfer (SCNT) in pigs. Transfection of PEFs with exogenous DNA is essential for producing genetically modified (GM; transgenic or knockout) pigs via SCNT. In this case, selectable markers are strictly required selecting and enriching stably transfected cells. The most frequently used selective drug for this purpose is a neomycin analogue (G418/geneticin); neo has been widely used as a selectable marker gene in the genomic manipulation of pigs. However, little is known about optimal concentrations of other selection drugs. This often hampers functional analysis of the porcine genome and development of individual GM pigs. This study explores the optimal concentrations of selective drugs, other than neomycin, that can be used for the selection of transfected PEFs. Porcine embryonic fibroblasts were incubated in media containing different concentrations of drugs for up to 10 days, to determine the optimal drug concentrations fatal for PEFs. The following concentrations were found to be optimal selective concentrations for use with PEFs: G418/geneticin, 400 µg/ml; blasticidin S, 8 µg/ml; hygromycin B, 40 µg/ml; puromycin, 2 µg/ml; and zeocin, 800 µg/ml. Repeated transfections with plasmids carrying selectable markers resulted in the generation of multidrug-resistant swine transfectants. Furthermore, these markers were found to be independent. The present information will be useful for the production of SCNT-mediated GM piglets that express multiple transgenes.


Subject(s)
Animals, Genetically Modified/embryology , Fibroblasts/ultrastructure , Nuclear Transfer Techniques/veterinary , Swine, Miniature/embryology , Acetyltransferases/genetics , Animals , Bleomycin/pharmacology , Cell Death/drug effects , DNA/analysis , Drug Resistance/genetics , Female , Fibroblasts/drug effects , Genetic Markers , Gentamicins/pharmacology , Gestational Age , Green Fluorescent Proteins/genetics , Hygromycin B/pharmacology , Nucleosides/pharmacology , Puromycin/pharmacology , Swine , Swine, Miniature/genetics , Transfection , Transgenes/genetics
9.
Nat Cell Biol ; 1(8): 479-85, 1999 Dec.
Article in English | MEDLINE | ID: mdl-10587643

ABSTRACT

Missense mutations in the human presenilin-1 (PS1) gene, which is found on chromosome 14, cause early-onset familial Alzheimer's disease (FAD). FAD-linked PS1 variants alter proteolytic processing of the amyloid precursor protein and cause an increase in vulnerability to apoptosis induced by various cell stresses. However, the mechanisms responsible for these phenomena are not clear. Here we report that mutations in PS1 affect the unfolded-protein response (UPR), which responds to the increased amount of unfolded proteins that accumulate in the endoplasmic reticulum (ER) under conditions that cause ER stress. PS1 mutations also lead to decreased expression of GRP78/Bip, a molecular chaperone, present in the ER, that can enable protein folding. Interestingly, GRP78 levels are reduced in the brains of Alzheimer's disease patients. The downregulation of UPR signalling by PS1 mutations is caused by disturbed function of IRE1, which is the proximal sensor of conditions in the ER lumen. Overexpression of GRP78 in neuroblastoma cells bearing PS1 mutants almost completely restores resistance to ER stress to the level of cells expressing wild-type PS1. These results show that mutations in PS1 may increase vulnerability to ER stress by altering the UPR signalling pathway.


Subject(s)
Endoplasmic Reticulum/metabolism , Heat-Shock Proteins , Membrane Proteins/metabolism , Mutation/genetics , Protein Folding , Signal Transduction , Alzheimer Disease/metabolism , Alzheimer Disease/pathology , Animals , Brain/metabolism , Brain/pathology , Calcimycin/pharmacology , Carrier Proteins/genetics , Carrier Proteins/metabolism , Cell Death/drug effects , Cell Line , Endoplasmic Reticulum/drug effects , Endoplasmic Reticulum Chaperone BiP , Endoribonucleases , HSP70 Heat-Shock Proteins/metabolism , Humans , Intracellular Membranes/metabolism , Membrane Proteins/genetics , Mice , Mice, Transgenic , Molecular Chaperones/genetics , Molecular Chaperones/metabolism , Neuroblastoma , Neurons/drug effects , Neurons/metabolism , Neurons/pathology , Phosphorylation , Presenilin-1 , Protein Binding , Protein Denaturation , Protein Serine-Threonine Kinases/genetics , Protein Serine-Threonine Kinases/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism , Signal Transduction/drug effects , Transfection , Tunicamycin/pharmacology
10.
J Med Genet ; 47(10): 704-9, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20577006

ABSTRACT

BACKGROUND: Mutations in TRPV4, a gene that encodes a Ca(2+) permeable non-selective cation channel, have recently been found in a spectrum of skeletal dysplasias that includes brachyolmia, spondylometaphyseal dysplasia, Kozlowski type (SMDK) and metatropic dysplasia (MD). Only a total of seven missense mutations were detected, however. The full spectrum of TRPV4 mutations and their phenotypes remained unclear. OBJECTIVES AND METHODS: To examine TRPV4 mutation spectrum and phenotype-genotype association, we searched for TRPV4 mutations by PCR-direct sequencing from genomic DNA in 22 MD and 20 SMDK probands. RESULTS: TRPV4 mutations were found in all but one MD subject. In total, 19 different heterozygous mutations were identified in 41 subjects; two were recurrent and 17 were novel. In MD, a recurrent P799L mutation was identified in nine subjects, as well as 10 novel mutations including F471del, the first deletion mutation of TRPV4. In SMDK, a recurrent R594H mutation was identified in 12 subjects and seven novel mutations. An association between the position of mutations and the disease phenotype was also observed. Thus, P799 in exon 15 is a hot codon for MD mutations, as four different amino acid substitutions have been observed at this codon; while R594 in exon 11 is a hotspot for SMDK mutations. CONCLUSION: The TRPV4 mutation spectrum in MD and SMDK, which showed genotype-phenotype correlation and potential functional significance of mutations that are non-randomly distributed over the gene, was presented in this study. The results would help diagnostic laboratories establish efficient screening strategies for genetic diagnosis of the TRPV4 dysplasia family diseases.


Subject(s)
Mutation , Osteochondrodysplasias/genetics , Osteochondrodysplasias/pathology , TRPV Cation Channels/genetics , DNA Mutational Analysis , Dwarfism/diagnostic imaging , Dwarfism/genetics , Dwarfism/pathology , Genotype , Humans , Mutation, Missense , Osteochondrodysplasias/diagnostic imaging , Phenotype , Polymerase Chain Reaction , Radiography , Sequence Analysis, DNA
11.
Reprod Domest Anim ; 46(5): 911-6, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21906188

ABSTRACT

Porcine embryonic fibroblasts (PEFs) have been used extensively as donor nuclei for the production of cloned pigs via somatic cell nuclear transfer (SCNT). Somatic cell nuclear transfer of gene-targeted PEFs has been the only way to produce gene-targeted pigs, given the lack of germ-line-competent porcine embryonic stem cells. Unlike other primary-cultured cells, such as murine embryonic fibroblasts, a single porcine PEF is unable to proliferate under normal conditions in which a certain number of PEFs (likely over 100) can grow normally. This limitation greatly hampers re-cloning of gene-modified PEFs, which is required for SCNT. Herein, we demonstrate the cultivation of a single PEF transfectant carrying the pEGFP-N1 plasmid with intact normal PEFs (>100) in a Terasaki microtest plate, which resulted in stimulation of the growth of the former cell (doubling time = 2.6 days). In contrast, when a single cell was cultured, it could typically divide only once and never divided more than twice. When a single transfectant was seeded in a well of a 96-well plate together with 5 × 10(4) untransfected PEFs and was subsequently selected in the presence of G418, we obtained a pure cell population of single-cell origin. Thus, this method should be useful for the purification of target recombinant pig clones from mosaic populations that cannot be cultured as a single cell or for which suitable cell growth-promoting conditions are unclear.


Subject(s)
Fibroblasts/cytology , Fibroblasts/physiology , Gene Expression Regulation/physiology , Green Fluorescent Proteins/metabolism , Swine, Miniature/embryology , Animals , Cell Line , Cell Proliferation , Green Fluorescent Proteins/genetics , Swine
12.
Gut ; 58(10): 1342-52, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19515638

ABSTRACT

BACKGROUND: Transient receptor potential (TRP)A1, a member of the TRP family of ion channels, has been proposed to function in diverse sensory processes, including thermosensation and pain. However, TRPA1 has not been directly implicated in stomach mechanosensation, and its contribution to acute visceral pain from this organ is unknown. Here, we investigated the expression of TRPA1 in primary sensory afferents and its involvement in visceral hypersensitivity in rats. METHODS: We examined TRPA1 expression in the dorsal root ganglion (DRG), nodose ganglion (NG), and stomach of rats by using immunohistochemistry. Electromyographic responses to gastric distention (GD) were recorded from the acromiotrapezius muscle in TRPA1 knockdown rats and in control rats. RESULTS: TRPA1 was predominantly expressed with sensory neuropeptides in DRG and NG neurons, and in nerve fibres in the rat stomach. Gastric distention induced the activation of extracellular signal-regulated protein kinase 1/2 (ERK1/2) in DRG and NG neurons 2 min after stimulation, and most of the phosphorylated-ERK1/2-labelled DRG neurons were TRPA1-positive neurons. Intrathecal injection of TRPA1 antisense attenuated the visceromotor response, and suppressed ERK1/2 activation in the DRG, but not NG, neurons produced by GD. Furthermore, intrathecal and intraperitoneal injections of the TRPA1 inhibitor HC-03003 suppressed the response to noxious GD. CONCLUSIONS: The activation of TRPA1 in DRG neurons by noxious GD may be involved in acute visceral pain. Our findings point to the potential blockade of TRPA1 in primary afferents as a new therapeutic target for the reduction of visceral hypersensitivity.


Subject(s)
Abdominal Pain/metabolism , TRPC Cation Channels/metabolism , Visceral Afferents/metabolism , Abdominal Pain/physiopathology , Afferent Pathways/metabolism , Afferent Pathways/physiopathology , Animals , Enzyme Activation/drug effects , Gastric Dilatation/metabolism , Gastric Dilatation/physiopathology , Male , Mitogen-Activated Protein Kinase 3/metabolism , Rats , Rats, Sprague-Dawley , Splanchnic Nerves/physiopathology , Staining and Labeling , TRPA1 Cation Channel , TRPC Cation Channels/antagonists & inhibitors
13.
J Cell Biol ; 155(4): 531-42, 2001 Nov 12.
Article in English | MEDLINE | ID: mdl-11706048

ABSTRACT

Functional development of mammary epithelium during pregnancy depends on prolactin signaling. However, the underlying molecular and cellular events are not fully understood. We examined the specific contributions of the prolactin receptor (PrlR) and the signal transducers and activators of transcription 5a and 5b (referred to as Stat5) in the formation and differentiation of mammary alveolar epithelium. PrlR- and Stat5-null mammary epithelia were transplanted into wild-type hosts, and pregnancy-mediated development was investigated at a histological and molecular level. Stat5-null mammary epithelium developed ducts but failed to form alveoli, and no milk protein gene expression was observed. In contrast, PrlR-null epithelium formed alveoli-like structures with small open lumina. Electron microscopy revealed undifferentiated features of organelles and a perturbation of cell-cell contacts in PrlR- and Stat5-null epithelia. Expression of NKCC1, an Na-K-Cl cotransporter characteristic for ductal epithelia, and ZO-1, a protein associated with tight junction, were maintained in the alveoli-like structures of PrlR- and Stat5-null epithelia. In contrast, the Na-Pi cotransporter Npt2b, and the gap junction component connexin 32, usually expressed in secretory epithelia, were undetectable in PrlR- and Stat5-null mice. These data demonstrate that signaling via the PrlR and Stat5 is critical for the proliferation and differentiation of mammary alveoli during pregnancy.


Subject(s)
DNA-Binding Proteins/physiology , Mammary Glands, Animal/cytology , Milk Proteins , Pregnancy, Animal , Trans-Activators/physiology , Animals , Cell Differentiation , Cell Division , Connexins/metabolism , Connexins/physiology , DNA-Binding Proteins/genetics , DNA-Binding Proteins/metabolism , Epidermal Growth Factor/administration & dosage , Epidermal Growth Factor/metabolism , Epithelial Cells/cytology , Female , Growth Hormone/administration & dosage , Growth Hormone/metabolism , Mammary Glands, Animal/anatomy & histology , Mammary Glands, Animal/embryology , Mice , Mice, Inbred C57BL , Mice, Knockout , Pregnancy , Receptors, Prolactin/genetics , Receptors, Prolactin/metabolism , Receptors, Prolactin/physiology , STAT5 Transcription Factor , Sodium-Potassium-Chloride Symporters/metabolism , Solute Carrier Family 12, Member 2 , Trans-Activators/genetics , Trans-Activators/metabolism , Gap Junction beta-1 Protein
14.
Science ; 159(3816): 736-7, 1968 Feb 16.
Article in English | MEDLINE | ID: mdl-17795070

ABSTRACT

Human metmyoglobin was separated electrophoretically into four subfractions: Mb(1), Mb(2), Mb(3), and Mb(4), which divide into at least two biochemically independent groups: Mb(1) and Mb(2), and Mb(3), and Mb(4). In normal subjects, Mb(1) constituted the predominant component; Mb(2), Mb(3), and Mb(4) were the minor components in this descending order. In the Duchenne type of progressive muscular dystrophy, on the contrary, a remarkable decrease in Mb(1) and a concomitant increase in Mb(3) were observed. This unique abnormality in the relative distribution of myoglobin subfractions was recognized only in the Duchenne type and not in other types of progressive muscular dystrophy or in other myopathies.

15.
J Clin Invest ; 108(12): 1781-8, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11748261

ABSTRACT

Immune and inflammatory systems are controlled by multiple cytokines, including ILs and INFs. These cytokines exert their biological functions through Janus tyrosine kinases and STAT transcription factors. One such cytokine, IL-6, has been proposed to contribute to the development of rheumatoid arthritis (RA). We found that STAT3 was strongly tyrosine phosphorylated in synovial tissue of RA patients, but not those with osteoarthritis. Blockade of the IL-6-gp130-JAK-STAT3-signaling pathway might therefore be beneficial in the treatment of RA. We show here that the mRNA for the endogenous cytokine signaling repressor CIS3/SOCS3 is abundantly expressed in RA patients. To determine whether CIS3 is effective in treating experimental arthritis, a recombinant adenovirus carrying the CIS3 cDNA was injected periarticularly into the ankle joints of mice with antigen-induced arthritis or collagen-induced arthritis (CIA). Periarticular injection of CIS3 adenovirus drastically reduced the severity of arthritis and joint swelling compared with control groups. CIS3 was more effective than a dominant-negative form of STAT3 in the CIA model. Thus, induction of CIS3 could represent a new approach for effective treatment of RA.


Subject(s)
Arthritis, Rheumatoid/therapy , Genetic Therapy , Proteins/genetics , Repressor Proteins , Signal Transduction , Transcription Factors , Animals , Cell Division , DNA-Binding Proteins/physiology , Disease Models, Animal , Humans , Interleukin-6/analysis , Male , Mice , Mice, Inbred C57BL , Mice, Inbred DBA , Proteins/physiology , RNA, Messenger/analysis , STAT3 Transcription Factor , Suppressor of Cytokine Signaling 3 Protein , Suppressor of Cytokine Signaling Proteins , Trans-Activators/physiology
16.
Neuroscience ; 144(3): 777-82, 2007 Feb 09.
Article in English | MEDLINE | ID: mdl-17156932

ABSTRACT

Chronic ethanol consumption produces a painful peripheral neuropathy. The aim of this study was then to investigate the mechanism underlying the neuropathic pain-like state induced by chronic ethanol treatment in rats. Mechanical hyperalgesia was clearly observed during ethanol consumption and even after ethanol withdrawal, and it lasted for, at least, 14 weeks. At 24 days after ethanol withdrawal, antinociception of morphine was significantly suppressed and the increased guanosine-5'-o-(3-thio) triphosphate ([(35)S]GTPgammaS) binding to membranes of the spinal cord induced by the selective mu-opioid receptor (MOR) agonist, [D-Ala(2),N-MePhe(4),Gly(5)-ol]enkephalin (DAMGO), was significantly decreased under the ethanol-dependent neuropathic pain-like state, whereas the increased [(35)S]GTPgammaS binding to membranes of the spinal cord induced by either the selective delta-opioid receptor (DOR) agonist or kappa-opioid receptor (KOR) agonist was not changed under the ethanol-dependent neuropathic pain-like state. Furthermore, total-MOR immunoreactivity was not changed in the spinal cord of ethanol-fed rats. Under these conditions, immunoblotting showed a robust increase in phosphorylated-cPKC immunoreactivity (p-cPKC-IR) in the spinal cord from chronic ethanol fed-rats, whereas phosphorylated-protein kinase A (PKA), dynamin II and G protein-coupled receptor kinase 2 (GRK2) were not affected in the spinal cord of ethanol-fed rats. These findings suggest that the dysfunction of MOR, but not DOR and KOR, linked to cPKC activation in the spinal cord may be, at least in part, involved in the reduced sensitivity to antinociception induced by morphine under the ethanol-dependent neuropathic pain-like state.


Subject(s)
Alcohol-Induced Disorders, Nervous System/metabolism , Opioid Peptides/metabolism , Peripheral Nervous System Diseases/chemically induced , Peripheral Nervous System Diseases/metabolism , Receptors, Opioid, mu/metabolism , Spinal Cord/metabolism , Alcohol-Induced Disorders, Nervous System/physiopathology , Analgesics, Opioid/pharmacology , Animals , Binding, Competitive/drug effects , Binding, Competitive/physiology , Central Nervous System Depressants/adverse effects , Enkephalin, Ala(2)-MePhe(4)-Gly(5)-/pharmacology , Ethanol/adverse effects , Guanosine 5'-O-(3-Thiotriphosphate)/metabolism , Hyperalgesia/chemically induced , Hyperalgesia/metabolism , Hyperalgesia/physiopathology , Male , Morphine/pharmacology , Neuralgia/metabolism , Neuralgia/physiopathology , Peripheral Nervous System Diseases/physiopathology , Phosphorylation/drug effects , Protein Kinase C/metabolism , Rats , Rats, Inbred F344 , Spinal Cord/physiopathology
17.
Mol Cell Biol ; 20(6): 2066-74, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10688653

ABSTRACT

A secretory defect causes specific and significant transcriptional repression of both ribosomal protein and rRNA genes (K. Mizuta and J. R. Warner, Mol. Cell. Biol. 14:2493-2502, 1994), suggesting the coupling of plasma membrane and ribosome syntheses. In order to elucidate the molecular mechanism of the signaling pathway, we isolated a cold-sensitive mutant with a mutation in a gene termed RRS1 (regulator of ribosome synthesis), which appeared to be defective in the signaling pathway. The rrs1-1 mutation greatly reduced transcriptional repression of both rRNA and ribosomal protein genes that is caused by a secretory defect. RRS1 is a novel, essential gene encoding a nuclear protein of 203 amino acid residues that is conserved in eukaryotes. A conditional rrs1-null mutant was constructed by placing RRS1 under the control of the GAL1 promoter. Rrs1p depletion caused defects in processing of pre-rRNA and assembly of ribosomal subunits.


Subject(s)
Fungal Proteins/genetics , Gene Expression Regulation, Fungal , Nuclear Proteins/genetics , Ribosomes/genetics , Ribosomes/metabolism , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae/metabolism , Amino Acid Sequence , Fungal Proteins/metabolism , Genes, Fungal , Molecular Sequence Data , Nuclear Proteins/metabolism , Sequence Alignment
18.
J Hum Hypertens ; 31(1): 66-69, 2017 01.
Article in English | MEDLINE | ID: mdl-27278927

ABSTRACT

Microalbuminuria is a risk factor for cardiovascular events and death in hypertensive patients. Patients who are expected to increase albuminuria need strict blood pressure control. In the present study, we assessed the association between the renal resistive index (RI) and future increases in albuminuria in patients with essential hypertension. Sixty-six patients with essential hypertension were included in the study. Univariate and multivariate logistic regression analyses were used to identify the factors, including renal RI, that were significant independent determinants of increased in urinary albumin excretion (UAE), defined as an increase of >50% in the urinary albumin-to-creatinine ratio over 2 years. Receiver operator characteristics curve analysis was used to select the optimal cut-off point that predicted an increase in UAE. RI was the only significant variable that predicted the increase in UAE, with the optimal cut-off value of renal RI that predicted this increase being 0.71 (sensitivity 52.4% and specificity 84.4%). Renal RI is associated with the future increase in albuminuria in patients with essential hypertension.


Subject(s)
Albuminuria/diagnostic imaging , Essential Hypertension/urine , Aged , Blood Flow Velocity , Essential Hypertension/diagnostic imaging , Female , Humans , Male , Middle Aged , Ultrasonography, Doppler, Pulsed
19.
J Phys Condens Matter ; 29(10): 105702, 2017 Mar 15.
Article in English | MEDLINE | ID: mdl-28145896

ABSTRACT

The effect of delithiation in Li x CoO2 is studied by high resolution Co K-edge x-ray absorption and x-ray emission spectroscopy. Polarization dependence of the x-ray absorption spectra on single crystal samples is exploited to reveal information on the anisotropic electronic structure. We find that the electronic structure of Li x CoO2 is significantly affected by delithiation in which the Co ions oxidation state tending to change from 3+ to 4+. The Co intersite (intrasite) 4p-3d hybridization suffers a decrease (increase) by delithiation. The unoccupied 3d t 2g orbitals with a 1g symmetry, containing substantial O 2p character, hybridize isotropically with Co 4p orbitals and likely to have itinerant character unlike anisotropically hybridized 3d e g orbitals. Such a peculiar electronic structure could have significant effect on the mobility of Li in Li x CoO2 cathode and hence the battery characteristics.

20.
Circ Res ; 88(6): 630-6, 2001 Mar 30.
Article in English | MEDLINE | ID: mdl-11282898

ABSTRACT

The platelet-derived growth factor (PDGF) ligands and their receptors have been implicated as critical regulators of the formation of arterial lesions after tissue injury. SU9518 (3[5-(5-bromo-2-oxo-1,2-dihydroindol-3-ylidenemethyl)-2,4-dimethyl-1H-pyrrol-3-yl]propionic acid) is a novel synthetic indolinone that potently and selectively inhibits the cellular PDGF receptor kinase and PDGF receptor-induced cell proliferation. Inhibition of PDGF receptor phosphorylation in cell-based assays occurs within 5 minutes after drug exposure and persists for >6 hours after drug removal. The pharmacokinetics indicate plasma levels that exceeded the effective concentration required to inhibit the PDGF receptor in cells for up to 8 hours or 7 days after a single oral or subcutaneous administration, respectively. In the rat balloon arterial injury-induced stenosis model, once-daily oral or once-weekly subcutaneous administration of SU9518 reduced intimal thickening of the carotid artery (ratio of neointimal to medial area, 1.94+/-0.38 versus 1.03+/-0.29 [P<0.01] 2.21+/-0.32 versus 1.34+/-0.45 [P<0.01], respectively). These studies provide the rationale to evaluate PDGF receptor tyrosine kinase inhibitors, including inhibitors related to the indolinone, SU9518, for the treatment of arterial restenosis.


Subject(s)
Carotid Stenosis/prevention & control , Enzyme Inhibitors/pharmacology , Indoles/pharmacology , Receptors, Platelet-Derived Growth Factor/antagonists & inhibitors , 3T3 Cells , Administration, Oral , Animals , Carotid Arteries/drug effects , Carotid Arteries/pathology , Carotid Stenosis/pathology , Cell Division/drug effects , Cell Movement/drug effects , Dose-Response Relationship, Drug , Enzyme Inhibitors/blood , Enzyme Inhibitors/pharmacokinetics , Fibroblasts/cytology , Fibroblasts/drug effects , Fibroblasts/metabolism , Humans , Injections, Subcutaneous , Kinetics , Mice , Muscle, Smooth, Vascular/cytology , Muscle, Smooth, Vascular/drug effects , Phosphorylation/drug effects , Platelet-Derived Growth Factor/pharmacology , Rats , Receptors, Platelet-Derived Growth Factor/metabolism , Tunica Intima/drug effects , Tunica Intima/pathology
SELECTION OF CITATIONS
SEARCH DETAIL